Teza Capital Management LLC Increases Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Teza Capital Management LLC increased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 7.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,066 shares of the company’s stock after buying an additional 434 shares during the period. Teza Capital Management LLC’s holdings in HCA Healthcare were worth $1,821,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Sanders Capital LLC lifted its position in HCA Healthcare by 1.0% in the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company’s stock valued at $3,498,417,000 after acquiring an additional 116,826 shares in the last quarter. First Eagle Investment Management LLC increased its stake in HCA Healthcare by 0.5% in the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock worth $1,351,830,000 after buying an additional 23,177 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of HCA Healthcare by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock valued at $1,159,882,000 after purchasing an additional 50,321 shares during the last quarter. Capital World Investors boosted its holdings in shares of HCA Healthcare by 0.7% during the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company’s stock valued at $878,975,000 after purchasing an additional 19,121 shares during the last quarter. Finally, Norges Bank bought a new position in shares of HCA Healthcare during the 4th quarter valued at about $840,286,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, COO Jon M. Foster sold 15,698 shares of the firm’s stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

HCA has been the subject of several analyst reports. StockNews.com raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Monday, April 28th. Guggenheim assumed coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They issued a “neutral” rating on the stock. Royal Bank of Canada lowered their price objective on shares of HCA Healthcare from $384.00 to $376.00 and set an “outperform” rating for the company in a research note on Monday, April 28th. Barclays lowered their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Finally, Bank of America decreased their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $381.13.

HCA Healthcare Stock Performance

NYSE:HCA opened at $387.49 on Friday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The stock has a market capitalization of $93.22 billion, a P/E ratio of 17.64, a PEG ratio of 1.10 and a beta of 1.46. The company has a 50 day moving average price of $340.72 and a 200 day moving average price of $328.51. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts’ consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion during the quarter, compared to analysts’ expectations of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The firm’s quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the company posted $5.36 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.74%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.81%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.